|
What exciting news! I wondered whether the trial was conducted on women who had not had a recurrence or whether that made any difference? Since it mentioned that it might be an alternative to herceptin, am I right in thinking that it could be a treatment for those with metastatic disease?
Thanks!
|
Hybrid Mode
